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Although specific antibody and complement have long been known to pro- 
duce  appreciable  bactericidal  effects on  Gram-negative  organisms,  in  vitro, 
the role of this phenomenon in immunity to infections with these organisms is 
still  not  clear  (1).  Similarly, certain  antibiotics,  including chloramphenicol, 
produce significant inhibition of the growth of Gram-negative bacteria in the 
test tube, and, in favorable instances, also exert a chemotherapeutic effect on 
infections such as typhoid fever. The quantitative correlations between these 
two actions of the drug are, however, not entirely defined nor is it known in 
satisfactory detail whether, in addition to the drug, immunity factors such as 
antibody, complement, and phagocytes play a significant part in recovery. 
In a  recent investigation (2)  it has been possible to determine with some 
precision the quantitative relations among antibody, complement, and bacteria 
which affect the bactericidal reaction. In a separate series of investigations in 
our laboratory, attention has been directed to the development of more precise 
methods of determining the  susceptibility of bacteria  to  antibiotics,  and to 
the interpretation of the data in terms of modes of action, at least on a popu- 
lational level (3). 
The convergence of these two lines of investigations has now permitted the 
establishment of a model in vitro system for the quantitative study of some of 
these therapeutic factors, and their interactions, with a greater precision than 
has been available with the methods used hitherto. Although important new 
information can be obtained, the approach is still inadequate so long as factors 
such as the participation of phagocytic cells are neglected. It is hoped, however, 
that the latter, in particular, may be included in a proposed extension of our 
procedures. 
* Supported by a grant from the National Science Foundation. The preliminary  method 
was developed under a grant from the National Institutes of Health, United States Public 
Health Service. 
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EXPERIMENTAL 
The general plan in all experiments was to study the inhibitory actions of 
the antibiotic and of the specific antibody plus complement,  separately,  and 
then in various combinations.  The  organisms  used  were  the Ty2  and 0901 
strains of S~ typhosa. Detailed descriptions of the materials and methods 
will be found in our other studies cited below. 
The basic features of each experiment were: 
1. A reaction period, during which the organisms were exposed to the in- 
hibitory agent or agents. 
2. The relative numbers of organisms surviving this period were then deter- 
mined by means of a  turbidimetric growth assay of a  subculture. The latter 
depended on the fact that the larger the number of viable organisms remaining, 
the more rapidly would the subculture grow in a given assay period. 
Bactcricldal Adion of Antibody and Complcr~nt.--The  t~hnique  employed was an  ex- 
tension of an ¢~rlier procedure (4). The details of the revised test, the variables affecting it, 
and its application to some problems in the serology of S. typhosa have been described re- 
cently (2). In brief, however, the test involves a series of test tubes. The first contains only 
broth, the others contain, in addition, a constant (nsually an excel) amount of complement, 
and a variable amount of the appropriate rabbit antiserum. Sufficient magnesium ion is added 
to all tubes to provide the optimum for bactericidal activity (2); all tubes are brought to con- 
stant volume with a  diluent. An accurately measured amount of culture is next added  to 
all tubes and the set is incubated in a water bath at 37°C. for the desired reaction period (in 
these experiments, 60 minutes). The assay of the surviving organisms may then be made by 
subculturing an aliquot, or more conveniently, 3 volumes of broth may be added directly to 
each tube. This effectively terminates the reaction, both by dilution of the antibody and com- 
plement, and by an anticomplementary action on the latter. It also serves to eliminate, for 
practical purposes, any contribution of residual, non-viable organisms to the final turbidity 
since considerable multiplication must ensue during this second incubation stage before the 
cultures reach readable densities. Further details on the controls employed are noted below. 
Re~ording of Rsadings.--After the set of tubes has reached a suitable reading range (with 
care being taken that the principal control is still in the log-growth phase) it is chilled in an 
ice water bath to check further growth, and the optical densities of the tubes are read in a 
Coleman  spectrophotometer  (wave  length-650  m#;  standard-unlnoculated  broth  con- 
trol) (2i. 
The simplest treatment of the data is based on the assumption that the relative  optical 
densities represent the relative  numbers of organisms present and (assuming a constant lag) 
that these in turn are directly  proportional to the number of viable organisms present at the 
end of the  reaction  period.  The appar~t percentagtJ  of  gro'a~th  can then be obtained by dividing 
the turbidimetric reading (in optical  density units) for each experimental tube by the optical 
density of  the  inoculated broth control,  and multiplying by I00.  Tubes controlling  the separate 
effects  of antibody or of complement should not differ  significantly  from the inoculated broth 
control standard. 
Although the apparent percentage  growths thus obtained  are reproducible experimental 
quantifies, and can be used directly  for many purposes, particularly  for comparative titra- 
tions, they do not represent immediately  the relative numbers of organisms surviving the 
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This may be readily demonstrated by inoculating a  series of plain broth tubes with graded 
numbers  of organisms and  incubating under the test conditions. The optical densities ob- 
tained do not fall on a straight line of 45  ° dope, but rather form a curve, with disportionately 
low readings for the larger initial inocula. This is probably due to the accumulation of acid 
or other metabolic products during growth, so that the lesding tubes are soon slowed  below 
the initial rate (2).  Nevertheless, by means of calibration curves these apparent percentages 
of growth--the simple ratios of experimental and control densities (X 100)--can be corrected 
to yield the true relative numbers of organisms. For convenience the latter are designated 
percentages of growth (corrected). All values reported in this paper have been so corrected. 
Linear Represent~ion of Data.--In experiments involving the inhibition of bacterial growth 
by antibody plus complement (2), or by an antibiotic (3), or by the combined actions of these, 
a plot of the percentages of growth against the logarithms of the amounts of inhibiting agent 
results generally in a  sigmoidal curve. This is, of course,  but a  special instance of a  wide- 
spread  biological dosage-response  relationship. As is well known,  the analytical  treatment 
of sigmoidal curves is cumbersome and a  great simplification can be effected by the probit 
transformation, which yields a linear plot (5). In practice this can be carried out with ease by 
plotting the percentage growth on special but readily available graph papers, 1 ruled with 
normal curve deviates for the ordinate percentages, and  logarithmic spacings for the drug 
or serum dosages.  In addition to the advantages of a linear plot, such graphs also yield a new 
parameter--the slope. Two dosage response lines must be parallel if a unique numerical value 
is to be assigned to an increase in drug resistance; in all other instances the comparison is 
dependent on the percentage inhibitions selected. 
Inhibition by an Antibiotic: Chloramphenicol.--The procedure here was similar to the above- 
with the substitution of graded amounts of the antibiotic in place of the antibody and corn, 
plement.  It  thus  resembled our turbidimetric antibiotic assay  (3),  except that  to provide 
comparable conditions the foregoing schedule of incubation,  followed by dilution and  sec- 
ondary assay incubation,  was followed. It should be noted,  in contrast  to the bactericidal 
Procedure, that while the activity of the antibiotic is reduced by the secondary dilution it 
does not cease,  and the final turbidities reached are affected by its presence during the two 
stages of incubation. The concentrations recorded are those of the reaction stage. 
The susceptibility  (or alternatively considered,  the resistance)  of a  culture can  be esti- 
mated  conveniently and  accurately from the amount  of antibiotic required to reduce the 
growth to 50 per cent of that of the control (3). This can be read off by inspection, from the 
(probit or normal deviate) percentage growth versus log drug concentration plot mentioned. 
The absolute reproducibility of the endpoints is indicated by a series of titrations made with 
the Ty2 cultures, on 6 separate days, over a period of 2 months. The 50 per cent endpoints 
were !.2,  1.4, 1.4, 1.1, 1.2, and  1.2 pg., from which may be computed an average of 1.25, 
and an average deviation of -4-0.10, or 8 per cent. These determinations were all made on 
broth-grown inocula; there are indications that suspensions from agar slants may differ from 
these in resistance but our series was too short to support this adequately. Until further in- 
formation is available, the inocula for series to be compared should all be prepared as uni- 
formly as possible. 
Combined Actions: Antibody, Complement, and Antibiotic 
These were all present  together  from  the  beginning  of the reaction  period, 
before addition of the test organisms.  In all other respects the conditions were 
as for the assays of the separate actions.  In some experiments  the amounts  of 
x Such as logarithmic normal paper,  No. 32.476,  Codex Book Co., Norwood, Massachu- 
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antibody  and  complement were  kept  constant,  while  the  amounts  of  the 
antibiotic were varied in the set. In other experiments these conditions were 
reversed.  In all cases control titrations of the separate activities were made 
along with each set. 
Antibiotic as Variable. 
In these experiments, performed with the Ty2 strain, the quantities of guinea pig comple- 
ment and anti-typhoid rabbit serum present in most of the tubes were constant. The two levels 
chosen were sufficient to reduce the growth by about 33 per cent, or 46 per cent; i.e.,  growth 
was 67 per cent, or 54 per cent, respectively, of that of the broth control. Variable amounts of 
chloramphenicol were also added in the experimental tubes, and in a control series which con- 
rained complement but lacked antibody. 
From the data given in Table I  and Fig. 1 it can be seen that the observed 
effect of antibody and complement plus the antibiotic is, within the experi- 
TABLE  I 
Observed and Calculc~ed Inhibitions by Chloramphenicol  in Presence and Absence of Bactericidal 
Antibody and Complement 
(For data of Fig. 1) 
Test organism: S. typhosa,  strain Ty2. 
Chloramphenicul 
present 
No antiserum 
added 
P  raPs 
~g.lml, 
0  O* 
0.17  0.28 
0.25  0.42 
0.38  0.56 
0.57  0.68 
0.84  0.80 
1.25  0.88 
1.88  0.91 
Average  deviation between  ob- 
served and  calculated  points, 
per cent .................... 
Amount of 1:3000 dilution of antiserum added 
0.30 ml.  0.S0 ml. 
P  observed  P  calculated 
0.33* 
0.52  0.52 
0.56  0.61 
0.64  0.71 
0.75  0.79 
0.85  0.87 
0.89  0.92 
0.92  0.94 
4.1 
P observed  P  calculated 
0.46* 
0.64  0.61 
0.69  0.69 
0.79  0.76 
0.84  0.83 
0.88  0.89 
0.91  0.94 
0.95  0.95 
1.9 
P  is the observed growth in the presence of antibiotic, expressed as the fraction of the 
control growth in broth. 
The expected inhibition is calculated from equation (1) of text: 
P  ----" P1 -b -P2(1  --  PI) 
in which P1 is the inhibition due to the constant level of antiserum present in the set and 
P2 is the inhibition due to varying level of antibiotic present in the set. 
* This is also the value of PI for this column (fraction of inhibition due to constant level 
of antiserum present). Note that for column 2,  PI  ffi  0. HENRY  P. TREFFERS  AND  LOUIS H. MUSCHEL  159 
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Fie. 1. Inlfibition of S. typkosa, strain Ty2. Curve A: effect of chioramphenicol alone. Curve 
B: the same in the presence of 0.30 nil. antiserum dilution and complement. Curve C: the 
same, in the presence of 0.50 ml. antiserum dilution. Note: Because of the logarithmic ab- 
seissae,  and thresholds of activity, the curves will approach closely but will not extrapolate 
exactly, in the region presented,  to the zero control values. 
mental  error,  precisely  that  expected  from  a  summation  of  the  individual 
inhibitory  effects. 
Antibody as Variable. 
In this series, illustrated in Fig. 2, complement was, as usual, held constant while variable 
amounts of antibody were added. 
The inhibition of growth due to the killing of a portion of the initial inoculum 
increased with added serum, both in the control series which lacked antibiotic 
(curve A),  and  in  the presence of amounts  of antibiotic  (0.25  or 0.50 #g.) 
which had they been added alone would have resulted in inhibitions of 43 per 
cent (curve B) or 65 per cent (curve C). 
Calculated  Points.--The  results expected on the hypothesis of joint,  inde- 
pendent actions may be calculated in simple fashion by either of two methods. 
The  first  assumes that  agent  I--for example,  antibody, plus complement-- 
reduces the initial  inoculum uniformly by a  given percentage. Thus,  for the 
first  illustration  above,  the  control  tube  containing  complement  plus  the 
smaller amount of antiserum,  0.30 ml.,  had  only 67 per cent of the growth 
given by the control containing broth alone (or broth plus complement, with- 
out serum). This condition should apply in all the other tubes in this set. We 160  COMBINED  ACTIONS  OF  ANTIBODY' AND  ANTIBIOTIC 
may next  consider  the effect of agent  II--here  chloramphenicol.  A  certain 
level of the latter,  such as 57 pg., resulted, in a control experiment, in an in- 
hibition of 68 per cent (32 per cent growth). It is characteristic of both of these 
types of agents  that  although  the  absolute numbers  of organisms  killed or 
inhibited will vary directly with the inoculum size, the percentage reduction 
will  be,  to  a  first approximation,  a  constant  independent  of  the  inoculum. 
Hence we may calculate that agent II will reduce by 68 per cent the number 
of organisms  escaping agent  I. This  new expected value, 67  per cent  ×  32 
per cent  =  21 per cent, of the original  inoculum, corresponds very weU with 
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FIG.  2. Inhibition of S. typhosa, Ty2.  Curve A: effect of antiserum (plus complement). 
Curve B: the same, in the presence of 0.25 pg. chloramphenicol. Curve C: the same, in the 
presence of 0.50 #g. chloramphenlcol. 
the observed value,  25 per cent. Alternatively,  this  latter value may be ex- 
pressed as an inhibition of 75 per cent. 
The calculation, in terms of inhibitions,  is expressed succinctly by an equa- 
tion given by Finney (reference  5, page 136). 
P  =- PI +  Ps  (1  -  P1)  (1) 
in which P is the total mortality (or inhibition) and P: and P~ are the mortalities 
(inhibitions)  resulting from agents I  and II applied separately. A calculation 
for the data of Fig. 1 is given in Table I; the computed values are also presented 
in Fig. 1. The average deviation for all points between the expected and ob- 
served inhibitions is 3.1 per cent. A similar calculation for the data of Fig. 2 
is given in Table II; the average deviation, for all points, is 2.8 per cent. HENRY  P.  TREFFERS  AND  LOUIS  H.  MUSCHEL  161 
Alternatively,  as  a  second method of calculation,  one may compute per- 
centages of growth utilizing as denominator the optical density for the control 
tube containing the agent common, in constant quantity, to all tubes in that 
set. This method, applied to the data of Fig.  1, would reduce the calculated 
points for curves B and C to points lying along curve A. 
TABLE II 
Comparison of Observed and Calculated Inkibitions after Bactericidal Aclion of Antibody and 
Complement, at Two Lards of Chloramphenicol 
(For data of Fig. 2) 
Inhibition 
Antiserum dilution  Curve A  Curve B  Curve C 
(1:1500) added  (no drug)  (0.25 ~g. drug)  (0.50~g. drug) 
Observed 
Wlt~. 
o 
0.05 
0.08 
o.12 
o.18 
0.27 
0.40 
0.60 
0.90 
~er ~ent 
o 
18 
29 
36 
38 
45 
54 
58 
65 
Average  deviation  between  ob- 
served  and  calculated  points, 
per cent ...................... 
Observed  ~)dcuhted 
/~r ~  ~r c~n.t 
43 
54  53 
58  6O 
62  64 
64  65 
69  69 
74  74 
76  76 
79  80 
3.0 
Observed  Cslculated 
per coo  l~er teal 
65 
7O  70 
72  75 
74  77 
8O  77 
82  80 
83  83 
83  85 
84  87 
2.5 
Drug-Resistant Organisms 
Chlorampkenicol-Resistant  S.  typkosa.--It  was  of  interest  to  determine 
whether the susceptibility to the bactericidal action of antibody and comple- 
ment would be altered by a  change in the level of susceptibility to an anti- 
biotic. To reduce the  hazards for laboratory infection with  a  drug-resistant 
strain,  the relatively avirulent 0901  strain of S.  typhosa was  chosen; it had 
been established previously that this strain is suited for quantitative measure- 
ment of bactericidal action (2). 
The resistant strain was selected by growing the stock culture of the 0901 
strain on agar plates containing a gradient of chloramphenicol (6). The parental 
strain and  the resistant  variant isolated from  it after several passages were 
titrated against the antibiotic, and also against an appropriate rabbit antiserum 
(2) and complement. This variant (resistant strain I) proved to have a chlor- 
amphenicol resistance,  in  terms of the relative amounts of drug required to 20 
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reach  the  50  per  cent endpoints,  almost  exactly twice that  of the  parental 
strain  (1.91  and  2.05  in  duplicate  titrations).  The amounts  of antibody re- 
quired for the 50 per cent inhibition endpoint, in the bactericidal tests were 
however, experimentally identical for the two strains (Table III). 
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Fro. 3. Susceptibility to bactericidal action of antibody and complement. Curve A: pa- 
rental strain of S. typhosa, 0901. Curve B: chloramphenicol-resistant  variant II. 
TABLE III 
Rdati~e Susceptibilities of Parental and Chloramphenicol-Resistant Strains of S. typhosa 0901 
to  Antibody  (plus  Complement), and  go  Chlorampheni~ol 
Endpoints *, 50 per cent inhibition of growth. 
Agent titrated 
Chioramphenicol 
Antiserum (with  complement) 
Endpoint for CM-resistant variant 
Endpoint for parental strain 
Resistant Strain I  Reaistant Strain II 
2.0*  4.2 
1.05*  0.89 
* Averages of duplicate determinations. 
By continued culture on drug-agar a  second variant  (resistant  strain  II) 
was isolated which was approximately fourfold more tolerant to the drug than 
was  the  parental  strain.  Nevertheless,  its  susceptibility  to  the  bactericidal 
action of antibody and complement appeared to be that of the parental strain, 
within the experimental error of a single titration (Table III). It will be noted 
from the parallelism of the lines for the comparable pairs (Fig. 3) that although HENRY  P.  TREI~I~ERS  AND  LOUIS  H.  MUSCHEL  153 
the 50 per cent endpoint was chosen for numerical tabulation,  any arbitrary 
endpoint would have served as well. 
DISCUSSION 
There  have  been a  number  of reports  that  in  infections  in  which  either 
specific antibody or antibiotic,  separately, have therapeutic effects the com- 
bination  may have  additive  value  (7-9).  In  some  instances  the  combined 
effect either in vitro  or in ~vo may be sufficiently greater than  those of the 
individual  components  so  as  to  suggest  synergism.  Some  of  the  reports 
cited involve Gram-positive organisms  and  thus presumably do not include 
bactericidal  effects.  In  all  instances  it  is  difficult  to  relate  the observed in 
v/~o effects to the in v/fro model systems which we have investigated, particu- 
larly when data  are lacking as  to  the relation  between a  given percentage 
reduction in the infecting dosage and the recovery rate. 
Of immediate pertinence to our data is the report of Hounie (10) that low 
concentrations of chloramphenicol (1: 5,000,000-1: 2,000,000)  which by them- 
selves do not have appreciable effects, may increase the sensitivity of organisms 
to  the  bactericidal  actions of blood. Miller  and  Foster  (11)  have  reported 
analogous properties for penicillin. 
The  availability  of  quantitative  assay  methods  of  some  sensitivity  has 
permitted the examination  of possible synergistic or antagonistic  effects be- 
tween a  bactericidal system composed of specific antibody and complement 
and an antibiotic, ch]oramphenicol,  active against the test organisms.  Under 
the conditions here employed the only effect observed was, however, that of 
joint but independent action; i.e.,  the total effect could be predicted quantita- 
tively from a knowledge of the activities of the separate components. It is of 
interest to note that  although  Finney (5) discussed the possible applications 
of formula (1)  above, he remarked that up to 1952 he had found no experi- 
mental data to illustrate its use; the present data would, however, appear to 
be satisfactorily expressed by it. As has already been implied above, the deri- 
vation of this formula assumes that the organisms escaping the action of the 
first agent are inhibited by the second agent in the same percentage as would 
have been the case had the second agent been added initially. 
The  rabbit  antiserum  employed  against  the  Ty2  strain  contained  both 
anti-O and anti-Vi antibodies; recent evidence (2) indicates that the particu- 
lar slope of curve A, Fig. 1, is a reflection of the fact that both antibodies are 
active here. 
The probit or normal deviate plot employed provides a linear representation 
of the data.  It is not to be expected, however, for this particular  scale  that 
curves B and C (Fig.  1) would be parallel to each other or to curve A. They 
are nevertheless related in that each original datumJthe percentage survival-- 
for the points of curve B  is a constant fraction of the value for the point on 164  COMBINED  ACTIONS  OF  ANTIBODY  AND  ANTIBIOTIC 
curve A lying immediately above it. Since the smaller amount of antiserum 
resulted in a constant inhibition of 33 per cent, the percentage  survival ob- 
viously is 67 per cent; the corresponding  values for curve C are 46 per cent 
and 54 per cent. These fixed percentages  of inhibition (or survival), and the 
characteristics of the normal deviate rulings,  result in a  tilting away of the 
lines, which increases with the magnitude of the constant inhibition incorpo- 
rated. 
As has been noted above,  the bactericidal  action of antibody and comple- 
ment is almost entirely confined to the reaction period  since the subsequent 
dilution for the assay effectively reduces  it to a  negligible fraction. The ac- 
tivity of the antibiotic is not terminated by any process analogous to an anti- 
complementary action, but is merely decreased by the dilution at a rate which 
should parallel  that of curve A, Fig. 1, except for secondary effects. No sepa- 
rate determination of the inhibition by the antibiotic during the assay stage 
itself need be made, however,  since curve A provides  a  complete  control for 
the antibiotic portion of the more complex inhibitions  detailed in curves  B 
and C. As far as the point of these experiments  is concerned,  the effective 
period  of antibiotic activity is  that of the reaction period;  any subsequent 
antibiotic activity in the absence  of antibody and complement  is merely a 
slight experimental  complication  which can adequately be allowed for. 
The experiments with the 0901 strain of S. typhosa are of interest in demon- 
strating that in these instances increases in resistance  to chloramphenicol  of 
from two- to fourfold are not accompanied  by any appreciable  change in sus- 
ceptibility to the bactericidal action of anti-O antibody and guinea pig com- 
plement. It is of value to compare this result with the experiments of Servant 
(12), who found that the total extractable polysaccharide content of S. typhosa, 
strain 0901, did not change  (within 2 per cent)  when the organism was "de- 
veloped"  for  resistance  to  dihydrostreptomycin, although  other  strains  of 
S, typhosa, S. enteritidis,  and E. coli decreased  in total extractable polysac- 
charide by as much as 300 per cent on becoming resistant to this antibiotic. 
Unless there are important individual differences attending the development 
of specific resistances to the various antibiotics, Servant's data would indicate 
that the 0901 strain of S. typkosa may be somewhat atypical for our purposes. 
Unfortunately, his paper was not noted until after the present experiments 
had been  completed  and the point could not be investigated further at this 
time. 
It would appear valid to assert from these experiments, despite their obvious 
limitations and exploratory character, that in recovery from typhoid fever 
the presence of an antibiotic such as chloramphenicol should not affect what- 
ever therapeutic role  may ultimately be assigned  to the serum bactericidal 
components,  so long as the organisms do not become drug-resistant. In what 
may be a special case, even the latter has been shown to be without deleterious HENRY  P.  TREI~'FERS  AND  LOUIS  H.  MUSCHEL  165 
effect on the bactericidal  action of antibody and complement.  Further  quan- 
titative experiments on a variety of drug-resistant strains are obviously needed 
to test the generality of this second conclusion. If the resistant organisms con- 
tain significantly variable amounts of specific polysaccharides, such experiments 
may also contribute to our understanding  of the bactericidal process. 
SUMMARY 
Quantitative  determinations,  employing turbidimetric  growth assays, have 
been made of the  inhibitory  actions of choramphenicol,  and of specific anti- 
body plus complement,  separately, and in combination.  In experiments  with 
the Ty2 strain  of S. typhosa the combined activities of the two groups of re- 
agents have been predicted, within 3 per cent, from the activities of the sepa- 
rate  components,  on  the  hypothesis  of  joint,  independent  action  (additive 
inhibitions).  A  fourfold increase in resistance  to chloramphenicol  of the 0901 
strain of S. typhosa has been shown to have little, if any, effect on its suscep- 
tibility to the bactericidal action of anti-O antibody and complement. Indirect 
evidence indicates  that  the latter may not be a  general  effect but may vary 
with the particular strain. 
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